The latest partnership deal from Flower One further expands the diversity of products that will be made available to retailers in Nevada
TORONTO, April 2, 2019 /CNW/ – Flower One Holdings Inc. ("Flower One" or the "Company") (CSE: FONE) (OTCQB: FLOOF) is pleased to announce a new long-term licensing agreement with The Medicine Cabinet, a high-end, boutique-style recreational cannabis brand that, through this partnership, will make its first foray into the United States market by way of Nevada. The addition of The Medicine Cabinet to Flower One’s growing portfolio of Brand Partners will allow the cannabis cultivator and producer to bring another product line to cannabis retailers, and therefore consumers, in Nevada.
"It’s our pleasure to announce Flower One’s latest brand partnership with The Medicine Cabinet. To be bringing this product portfolio to the United States for the very first time is a point of pride for Flower One," said Ken Villazor, President and CEO of Flower One. "We’re excited to further diversify the brands and product we’re able to offer Nevada’s retailers and to continue establishing ourselves as a leader in the cannabis industry."
"With 42 million tourists visiting Las Vegas every year, there couldn’t be a better American market for us to put The Medicine Cabinet products in front of – and we’re thrilled to be partnered with a recognizable producer like Flower One for fulfillment," said a representative from The Medicine Cabinet. "After visiting the Flower One facility and getting to know the team’s executives and experienced growers, we were confident that this partnership would ensure our initial arrival in Nevada, and the United States in general, is a success. With Flower One’s up and coming cultivation and production capabilities, we’re at ease knowing that we’ll be able to continue delivering high quality, Ultra Premium Cannabis in and throughout our product and brands."
Soon to be available in Nevada are The Medicine Cabinet’s Don Pablo Premium pre-rolls, a selection of Bomb Girl’s edibles and pre-roll Slims and Baby J’s, as well as a variety of Coffeeshop Classics dried flower.
About Flower One Holdings Inc.
Flower One is sharply focused on quickly becoming the leading cannabis cultivator, producer and innovator in the highly lucrative Nevada market. Flower One is rapidly converting its 455,000 square foot greenhouse and production facility, the largest in the State of Nevada, for the cultivation and production of high-quality cannabis at scale. It also owns and operates a 25,000 square foot indoor cultivation and production facility in North Las Vegas, with nine grow rooms, and owns the established NLV Organics consumer brand of cannabis products. Combined, the flagship greenhouse and production facility and the North Las Vegas facility provide Flower One with 480,000 square feet of capacity for cultivation and processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products. Flower One is fully licensed for medical and recreational marijuana cultivation and production in the state of Nevada and currently holds licensing agreements with their Brand Partners, Flyte Concentrates, Rapid-Dose Therapeutics’ Quick Strip, Old Pal, Palms, HUXTON, CannAmerica Brands, G Pen, and The Medicine Cabinet.
Flower One’s common shares are traded on the Canadian Securities Exchange under the symbol "FONE" and in the United States on the OTCQB under the symbol "FLOOF." For more information visit: https://flowerone.com
About The Medicine Cabinet
The Medicine Cabinet seeks to provide a variety of high end, boutique-style recreational products and brands, including: Don Pablo’s signature line of hand rolled Premium Classics and Premium Exotics, Bomb Girl’s sleek selection of pre-rolled Baby J’s, and Slims, and for the connoisseur, Coffeeshop Classics, the finest in superior flavours and aromas. The Medicine Cabinet is dedicated to cultivating only the highest quality of Ultra Premium Cannabis delivered in the most innovative products and brands to medical and recreational users. For more information, visit https://themedicinecabinet.com
Cautionary Note Regarding Forward Looking Information
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Flower One’s public documents. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward- looking statements.
Forward-looking statements may include, without limitation, statements relating to the execution of the Company’s strategy and intent to quickly become the leading cannabis cultivator, producer and innovator in Nevada; the profitability of Flower One’s activities in Nevada; the number of tourists visiting Las Vegas every year; the scale and capacity of Flower One’s cultivation, processing and high-volume packaging facilities in Nevada; Flower One’s ability to expand its cannabis offerings in Nevada or to offer the most cutting-edge cannabis experience; Flower One’s ability to make The Medicine Cabinet’s product series available in Nevada or to offer a diversity of products; the term of the licensing agreement with the Medicine Cabinet; Medicine Cabinet’s ability to continue delivering high quality, Ultra Premium Cannabis in and throughout our product and brands; and the potential quality and effects of The Medicine Cabinet’s product series.
Although Flower One has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects that are engaged in activities currently considered illegal under United States federal law; changes in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Flower One Holdings disclaims any intention or obligation to update or revise such information, except as required by applicable law.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR THEIR REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE Flower One Holdings Inc.